Advertisement

FDA approves first pill to treat all forms of hepatitis C

By Associated Press  |  June 28, 2016

Federal health officials have approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus.

Drug companies fight generics with coupons

Drug companies fight generics with coupons

By Howard Wolinsky  |  June 11, 2016

Drugmakers are making increased use of consumer coupons, which are designed to thwart the high copays used by pharmacy benefit managers and insurers to channel consumers to less-costly generic drugs.

McKesson Corp. weighs separation from its IT unit

By Modern Healthcare  |  June 04, 2016

McKesson Corp. may be weighing a separation of its information technology unit as it works to contain costs and refocus on its core drug distribution business, according to the Wall Street Journal.

FDA streamlines application process for 'compassionate use'

By Steven Ross Johnson  |  June 02, 2016

The Food and Drug Administration on Thursday finalized its updated application process intended to shorten the time it takes terminally ill patients to gain access to experimental drugs under the agency's “compassionate use” program.

FDA delay raises slim hope for muscular dystrophy drug

By Associated Press  |  May 25, 2016

The Food and Drug Administration will take more time to review a highly contested drug for muscular dystrophy that has become a flashpoint in the debate over patient access to experimental medicine.

Tapping new dimensions: the promise of 3-D printing

Tapping new dimensions: the promise of 3-D printing

By Adam Rubenfire  |  May 21, 2016

Physicians have increasingly looked to 3-D printing for unique implants and surgical models, and some manufacturers are now using the method to mass produce medical devices and even drugs that are more precise, customizable and biocompatible than conventionally produced products.

Editorial: What's a new cancer drug worth?

Editorial: What's a new cancer drug worth?

By Merrill Goozner  |  May 21, 2016

While the latest cancer drugs emerging from drug and biotechnology company labs can come with hefty price tags, they don't necessarily have a lot of evidence showing they actually work.

Innovations: Making 3-D medical imaging a reality

Innovations: Making 3-D medical imaging a reality

By Beth Kutscher  |  May 14, 2016

EchoPixel likes to compare its 3-D imaging technology to cutting through a loaf of bread. MRIs and CT scans can create flat, two-dimensional pictures—or single slices—of information. But what if you wanted to cut into the loaf from a different angle to get more detailed cross sections?

FDA finalizes reporting rule for antibiotic use in livestock

By Steven Ross Johnson  |  May 13, 2016

Manufacturers of antibiotics used in food-producing animals must now provide their estimated sales, by species, of the drugs they sell and distribute for that purpose, according to a final rule from the Food and Drug Administration.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.